Sign in

CIK 0001799788

  • Non-accelerated filer
  • Smaller reporting company

Greenwich LifeSciences, Inc.

Sign in to watch
Ticker
GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205473709
Phone
+1 203-434-3290
Business address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-12-24 McWilliams David Director Grant or award · Stock Options +61,984 123,968
2022-06-22 McWilliams David Director Grant or award · Stock Options +61,984 61,984
2021-12-14 McWilliams David Director Purchase +200 $27.56 $6K 620,301
2020-11-20 McWilliams David Director Purchase +1,500 $5.40 $8K 620,101
2020-09-29 McWilliams David Director Exercise or conversion +152,604 599,583
2020-09-29 McWilliams David Director Exercise or conversion +7,663 607,246
2020-09-29 McWilliams David Director Exercise or conversion +3,746 610,992
2020-09-29 McWilliams David Director Exercise or conversion +7,609 618,601
2020-09-29 McWilliams David Director Exercise or conversion · Series A Preferred Stock −152,604 0
2020-09-29 McWilliams David Director Exercise or conversion · Series B Preferred Stock −7,663 0
2020-09-29 McWilliams David Director Exercise or conversion · Series C Preferred Stock −3,746 0
2020-09-29 McWilliams David Director Exercise or conversion · Series D Preferred Stock −6,555 0
2020-09-29 McWilliams David Director Other acquisition · Series D Preferred Stock +1,054 1,054
2020-09-29 McWilliams David Director Exercise or conversion · Series D Preferred Stock −1,054 0
2020-09-29 McWilliams David Director Purchase +2,608 $5.75 $15K 446,979

Page 1 of 1 · 15 trades